82 related articles for article (PubMed ID: 27793672)
1. Critical involvement of the orbitofrontal cortex in hyperlocomotion induced by NMDA receptor blockade in mice.
Seiriki K; Kasai A; Kuwaki T; Nakazawa T; Yamaguchi S; Hashimoto H
Biochem Biophys Res Commun; 2016 Nov; 480(4):558-563. PubMed ID: 27793672
[TBL] [Abstract][Full Text] [Related]
2. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
[TBL] [Abstract][Full Text] [Related]
3. Maslinic acid ameliorates NMDA receptor blockade-induced schizophrenia-like behaviors in mice.
Jeon SJ; Kim E; Lee JS; Oh HK; Zhang J; Kwon Y; Jang DS; Ryu JH
Neuropharmacology; 2017 Nov; 126():168-178. PubMed ID: 28899728
[TBL] [Abstract][Full Text] [Related]
4. Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice.
Gomes FV; Issy AC; Ferreira FR; Viveros MP; Del Bel EA; Guimarães FS
Int J Neuropsychopharmacol; 2014 Oct; 18(5):. PubMed ID: 25618402
[TBL] [Abstract][Full Text] [Related]
5. Age-related differential sensitivity to MK-801-induced locomotion and stereotypy in C57BL/6 mice.
Qi C; Zou H; Zhang R; Zhao G; Jin M; Yu L
Eur J Pharmacol; 2008 Feb; 580(1-2):161-8. PubMed ID: 18053981
[TBL] [Abstract][Full Text] [Related]
6. Guanosine selectively inhibits locomotor stimulation induced by the NMDA antagonist dizocilpine.
Tort AB; Mantese CE; dos Anjos GM; Dietrich MO; Dall'Igna OP; Souza DO; Lara DR
Behav Brain Res; 2004 Oct; 154(2):417-22. PubMed ID: 15313029
[TBL] [Abstract][Full Text] [Related]
7. Clozapine Improves Behavioral and Biochemical Outcomes in a MK-801-Induced Mouse Model of Schizophrenia.
Andrabi SS; Vishnoi S; Madan R; Bhardwaj N; Tabassum H; Akram M; Parvez S
J Environ Pathol Toxicol Oncol; 2020; 39(1):1-12. PubMed ID: 32479008
[TBL] [Abstract][Full Text] [Related]
8. Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice.
Wu J; Zou H; Strong JA; Yu J; Zhou X; Xie Q; Zhao G; Jin M; Yu L
Psychopharmacology (Berl); 2005 Jan; 177(3):256-63. PubMed ID: 15290006
[TBL] [Abstract][Full Text] [Related]
9. Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801.
Ninan I; Kulkarni SK
Indian J Physiol Pharmacol; 1998 Jul; 42(3):375-82. PubMed ID: 9741652
[TBL] [Abstract][Full Text] [Related]
10. Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine.
Zhang L; Shirayama Y; Iyo M; Hashimoto K
Neuropsychopharmacology; 2007 Sep; 32(9):2004-10. PubMed ID: 17228338
[TBL] [Abstract][Full Text] [Related]
11. Prefrontal cortex lesions cause only minor effects on the hyperlocomotion induced by MK-801 and its reversal by clozapine.
Scorza MC; Meikle MN; Hill XL; Richeri A; Lorenzo D; Artigas F
Int J Neuropsychopharmacol; 2008 Jun; 11(4):519-32. PubMed ID: 18248688
[TBL] [Abstract][Full Text] [Related]
12. MK-801 suppresses muricidal behavior but not locomotion in olfactory bulbectomized rats: involvement of NMDA receptors.
Ho YJ; Chen KH; Tai MY; Tsai YF
Pharmacol Biochem Behav; 2004 Mar; 77(3):641-6. PubMed ID: 15006477
[TBL] [Abstract][Full Text] [Related]
13. Voluntary wheel running ameliorates symptoms of MK-801-induced schizophrenia in mice.
Kim TW; Kang HS; Park JK; Lee SJ; Baek SB; Kim CJ
Mol Med Rep; 2014 Dec; 10(6):2924-30. PubMed ID: 25323073
[TBL] [Abstract][Full Text] [Related]
14. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist.
Perera PY; Lichy JH; Mastropaolo J; Rosse RB; Deutsch SI
Eur Neuropsychopharmacol; 2008 Nov; 18(11):814-9. PubMed ID: 18674888
[TBL] [Abstract][Full Text] [Related]
15. Effect of riluzole on MK-801 and amphetamine-induced hyperlocomotion.
Lourenço Da Silva A; Hoffmann A; Dietrich MO; Dall'Igna OP; Souza DO; Lara DR
Neuropsychobiology; 2003; 48(1):27-30. PubMed ID: 12886037
[TBL] [Abstract][Full Text] [Related]
16. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats.
Kawaura K; Koike H; Kinoshita K; Kambe D; Kaku A; Karasawa J; Chaki S; Hikichi H
Behav Brain Res; 2015 Feb; 278():186-92. PubMed ID: 25300471
[TBL] [Abstract][Full Text] [Related]
17. Selective enhancement of NMDA receptor-mediated locomotor hyperactivity by male sex hormones in mice.
van den Buuse M; Low JK; Kwek P; Martin S; Gogos A
Psychopharmacology (Berl); 2017 Sep; 234(18):2727-2735. PubMed ID: 28674745
[TBL] [Abstract][Full Text] [Related]
18. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens.
Mathé JM; Nomikos GG; Schilström B; Svensson TH
J Neurosci Res; 1998 Mar; 51(5):583-92. PubMed ID: 9512002
[TBL] [Abstract][Full Text] [Related]
19. MK-801-induced and scopolamine-induced hyperactivity in rats neonatally treated chronically with MK-801.
Furuie H; Yamada K; Ichitani Y
Behav Pharmacol; 2013 Dec; 24(8):678-83. PubMed ID: 24113081
[TBL] [Abstract][Full Text] [Related]
20. Neonatal exposure to MK-801, an N-methyl-D-aspartate receptor antagonist, enhances methamphetamine-induced locomotion and disrupts sensorimotor gating in pre- and postpubertal rats.
Uehara T; Sumiyoshi T; Seo T; Matsuoka T; Itoh H; Suzuki M; Kurachi M
Brain Res; 2010 Sep; 1352():223-30. PubMed ID: 20633540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
